ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA. (2024). Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 731-740. https://doi.org/10.53555/nhwgvd87